New therapeutic agents for castration-refractory prostate cancer

Clin Genitourin Cancer. 2009 Aug;7(2):E4-6. doi: 10.3816/CGC.2009.n.013.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Androstenes
  • Androstenols / therapeutic use
  • Benzamides
  • Endothelins / antagonists & inhibitors
  • Humans
  • Male
  • Nitriles
  • Orchiectomy
  • Phenylthiohydantoin / analogs & derivatives
  • Phenylthiohydantoin / therapeutic use
  • Prostatic Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / therapeutic use
  • Receptors, Androgen / physiology
  • Thalidomide / therapeutic use
  • Tissue Extracts / therapeutic use

Substances

  • Androstenes
  • Androstenols
  • Benzamides
  • Endothelins
  • Nitriles
  • Protein Kinase Inhibitors
  • Receptors, Androgen
  • Tissue Extracts
  • Phenylthiohydantoin
  • Thalidomide
  • sipuleucel-T
  • enzalutamide
  • abiraterone